{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-002370","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.494663+00:00","generated_at":"2026-05-24T00:05:11.688083+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"SBC Medical names Miki Shimizu as Chief Strategy Officer; Komatsu moves to Japan sub role","bullets":["Board approved on March 27, 2025; effective April 10, 2025.","Miki Shimizu will become Chief Strategy Officer, replacing Akira Komatsu.","Akira Komatsu transitions to Chief of Group Representative Office for SBC Medical Group Co., Ltd. (Japan).","Both roles are within SBC Medical Group Holdings Incorporated or its subsidiary."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-002370","json":"https://secwatch.observer/filing/0001641172-25-002370.json","markdown":"https://secwatch.observer/filing/0001641172-25-002370.md","text":"https://secwatch.observer/filing/0001641172-25-002370.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/0001641172-25-002370-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T00:05:11.688083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fcabb456a","claim":"Miki Shimizu was appointed as Chief Strategy Officer at SBC Medical Group Holdings Inc.","evidence_excerpt":"effective April 10, 2025, Miki Shimizu will assume the role of Chief Strategy Officer of the Company, a position currently held by Akira Komatsu.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/0001641172-25-002370-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Strategy Officer"}],"fact_type":"executive_change"},{"claim_id":"fefe4c8732","claim":"Akira Komatsu was appointed as Chief of the Group Representative Office at SBC Medical Group Holdings Inc.","evidence_excerpt":"As of such transition date, Mr. Komatsu will hold the position of Chief of the Group Representative Office for SBC Medical Group Co., Ltd. (Japan), a subsidiary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/0001641172-25-002370-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief of the Group Representative Office"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}